Exercise + Brain Stimulation for Vascular Cognitive Impairment
(EXPRESS-V Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how exercise and brain stimulation can improve memory in individuals with heart-related conditions at risk of cognitive decline. It compares different combinations of exercise and transcranial direct current stimulation (tDCS), a technique believed to boost brain activity. Participants are divided into groups receiving either active tDCS, a sham version, or just exercise guidance. This trial suits those with heart problems, memory struggles, and the ability to exercise at a moderate level. As an unphased trial, it provides a unique opportunity to contribute to understanding new methods for enhancing memory and brain function.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you have changed psychotropic medications in the last 4 weeks or are currently using benzodiazepines, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that transcranial direct current stimulation (tDCS) is generally safe for people. Studies indicate that tDCS can be used safely for up to 20 days without causing serious side effects. The most common side effects are mild, such as tingling or itching on the skin.
When combining exercise with tDCS, both are safe individually. Exercise improves brain health, and tDCS works well on active brain cells, like those engaged during exercise. This combination is believed to enhance positive effects on brain function.
In summary, both exercise and tDCS have strong safety records, with only mild and temporary side effects. This makes them promising options for people at risk of cognitive decline.12345Why are researchers excited about this trial's treatments?
Researchers are excited about combining exercise with brain stimulation techniques like transcranial direct current stimulation (tDCS) for vascular cognitive impairment because this approach targets brain health in a novel way. Unlike traditional treatments that mainly focus on managing risk factors such as blood pressure and cholesterol, these interventions aim to enhance cognitive function directly. Exercise alone is known to improve overall health, but when combined with tDCS, it may boost brain activity by gently stimulating specific brain areas. This synergy has the potential to improve cognitive functions more effectively and quickly than current methods.
What evidence suggests that this trial's treatments could be effective for vascular cognitive impairment?
Research has shown that exercise, one of the treatments in this trial, can greatly improve thinking skills in people with vascular cognitive impairment. Studies have found that aerobic exercise boosts memory and delays the onset of dementia. Exercise also protects the brain from damage caused by small blood vessel disease, which can lead to memory problems.
Transcranial direct current stimulation (tDCS), another treatment option in this trial, has shown mixed results. Some studies suggest tDCS can improve thinking in people with conditions like schizophrenia and depression. However, it has not significantly improved memory in older adults with memory issues. When combined with other treatments, such as cognitive rehabilitation, tDCS might help enhance thinking skills.678910Who Is on the Research Team?
Krista Lanctôt, PhD
Principal Investigator
Sunnybrook Research Institute
Are You a Good Fit for This Trial?
This trial is for English-speaking adults over 50, especially post-menopausal women, with cardiovascular risks or disease and mild memory issues. They must be able to exercise moderately but can't have had a stroke, recent psychotropic medication changes, benzodiazepine use, metal implants affecting brain stimulation safety, or significant neurological/psychiatric conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to one of four interventions: Exercise primer with tDCS, Treatment as usual with tDCS, Exercise primer with sham tDCS, or Treatment as usual with sham tDCS. Interventions include exercise and/or tDCS.
Follow-up
Participants are monitored for cognitive and behavioral changes after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Exercise
- Sham stimulation
- tDCS
- Treatment as usual
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sunnybrook Health Sciences Centre
Lead Sponsor